Andera Partners

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers. 177Lu-satoreotide tetraxetan (Satoreotide), the company's primary targeted systemic radiopharmaceutical therapy, is an antagonist of the somatostatin type 2 receptor (SSTR2), which is overexpressed in many neuroendocrine tumors. For the simultaneous diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, some aggressive tumors, and childhood cancer, which currently offers few treatment choices and a poor prognosis, we are developing satoreotide as a "theranostic" pair.

MMI S.r.l manufactures and develops micro instruments to support surgical interventions at a dimensional scale. The company develops wristed micro instruments and their fabrication process. The company also develops and offers robotic platform. The company's proprietary robotic platform and wristed micro instruments simplifies reconstruction procedures after traumatic injuries and after tumor removal in breast, head, and bones. The company was founded in 2015 and is headquartered in Calci, Italy.

Resonance Imaging Group provides all patients with access to medical imaging, for increasingly precise diagnoses.

HR Path is a global consultancy specializing in human capital management, with a focus on HR Systems Integration, HR Outsourcing, and HR Business Consulting. Founded in 2001 by François Boulet and Cyril Courtin, the company is headquartered in Paris and operates in 13 countries across North America, Europe, and the Middle East, employing over 500 consultants. HR Path offers a range of software solutions, including proprietary tools like BiHRdy for business intelligence, Pandore for HR and payroll management, and Geef for talent management. Additionally, it serves as an authorized reseller for various software solutions in the French market, including those from SAP and Oracle HCM. With a diverse client portfolio that includes large corporations, small and medium-sized enterprises, and public sector organizations, HR Path generates approximately €60 million in annual revenue, supporting clients in their digital transformation and enhancing the efficiency of HR operations through technology.

Tubulis GmbH, founded in 2019 and based in Munich, Germany, focuses on the research, design, and development of protein-drug conjugates by integrating proprietary technologies with disease-specific biology. The company aims to transform the therapeutic landscape by creating innovative antibody-drug conjugates (ADCs) that enhance treatment outcomes for patients. Tubulis is dedicated to identifying new protein-drug combinations for various therapeutic applications, thereby expanding the potential of ADCs in addressing unmet medical needs.

Kyotherm SAS is an investment company based in Paris, France, that focuses on financing renewable heating and energy efficiency projects. Established in 2011, it provides project equity to support the development of energy infrastructure and acquires stakes in various renewable energy production initiatives, including geothermal and biomass heating plants, as well as district heating networks. Kyotherm collaborates with a range of stakeholders, including energy service providers, engineering firms, developers, heat consumers, and equipment manufacturers, to facilitate third-party financing for these projects.

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Lhyfe is a company based in Nantes, France, that specializes in the design, development, and operation of industrial sites for the production of green hydrogen sourced from renewable energy. Established in 2017, Lhyfe focuses on supplying 100% green hydrogen to support mobility and industrial applications. The company's commitment to sustainable energy solutions positions it as a key player in the transition towards greener energy sources.

exciva is a Provider of targeted drug rescue program intended to involve pharmaceutical research and development based in Heidelberg, Germany. The company's program has been formulated for developing symptomatic and disease-modifying treatments, therapies, cures, prophylactics, supplements, formulations and methods of making and using such compositions, enabling the healthcare industry to access their program for rescuing and reusing approved drugs for new indications and new uses.

Evommune, Inc. develops and manufactures tissue-based medicines for inflammatory diseases. It offers medicines for immunology and dermatology. The company was incorporated in 2020 and is based in Los Altos, California.

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.

Manufacturer of vehicle-mounted access platforms. The company engages in the manufacturing of vehicle-mounted elevators and platforms for various types of commercial vehicles and trucks, enabling users to seamlessly carry out their tasks.

MC2-Technologies develops innovative equipment for the protection of sites or sensitive infrastructures.

AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Atlantic Therapeutics is a medical technology company that develops pelvic floor muscle strengthening and nerve stimulation products. The company's devices focus on the treatment of all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor, enabling bladder patients to treat their conditions associated with pelvic floor weakness. Its products are backed by strong clinical evidence and subjected to controlled trials. It was established in Galway, Galway in 2013.

Medlumics S.L. designs and manufactures catheter based systems for the treatment of supra ventricular tachycardias. The company develops integrated photonic devices using optical coherence tomography technology, a light based diagnostic technique to provide sectional information about tissue. Medlumics S.L. was founded in 2009 and is based in Tres Cantos, Spain.

Sogetrel is a major player in the telecoms market. Integrator of networks and communication systems for digital irrigation of territories, the Group has established itself as the preferred partner of major operators, public and private contractors, and local authorities, particularly in the deployment of Very High Speed ​​networks.

SIRSA develops Reporting 21, a Software as a Service platform for the collection and analysis of financial and extra-financial data. It serves businesses and financial institutions. The company was incorporated in 2014 and is based in Paris, France.

ReViral is a developer of antiviral drugs designed to help patients and enlarge the antiviral market by developing novel first-in-class compounds. The company's antiviral drugs is a fusion inhibitor of RSV which is a highly potent, novel small molecule and is being developed to treat RSV in patients with severe disease including neonates, enabling patients to be treated who are infected with respiratory syncytial virus (RSV) by developing novel compounds.

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.

Arvelle Therapeutics GmbH, a biopharmaceutical company, focuses on solutions for patients suffering from CNS disorders. It is involved in the development and commercialization of cenobamate, an investigational antiepileptic drug in the European market. The company was founded in 2019 and is headquartered in Zug, Switzerland.

Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.

AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derived peptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

Grey Wolf Therapeutics, a biotechnology company, develops immunotherapies that illuminate non-responsive tumors for destruction by the immune system. The company was incorporated in 2017 and is based in Oxford, United Kingdom.

MasterGrid is a manufacturer and supplier of high voltage electrical equipment based in Grenoble, France. Formerly known as Merlin Gerin, the company was incorporated in 2019 and focuses on providing electric products, solutions, and services tailored to the needs of both the commercial and industrial sectors.

Opportunity SAS is a company based in Paris, France, founded in 2005, specializing in debt recovery and risk management solutions. It provides a comprehensive range of services including payment reminders, card protection, survey design, personal video communications, video signatures, record signatures, push notifications, and mail services. Additionally, Opportunity offers multi-channel delivery capabilities, data integration, and portal services. The company also focuses on marketing automation and provides a software as a service (SaaS) platform for customer interaction management. Opportunity is recognized for its commitment to enhancing digital customer relationship management projects, serving clients across various sectors both in France and internationally.

Olaqin SAS is a company based in Suresnes, France, specializing in the distribution of electronic healthcare transaction management systems, software, and integrated solutions. Founded in 2012, Olaqin offers a range of products including electronic transaction and payment processing devices, such as self-service, counter, fixed, and mobile solutions, as well as mixed health and banking solutions. The company serves pharmacies, healthcare professionals, and medical institutions, providing essential tools for managing health transactions efficiently. Olaqin was previously known as Ingenico Healthcare France before rebranding in November 2019. Its focus is on facilitating transactions within the healthcare sector.

Inotrem S.A. is a biotechnology company based in Paris, France, specializing in the discovery and development of innovative treatments for inflammatory pathologies, particularly in critical care settings. Founded in 2013, the company focuses on immunotherapy and has created a novel immunomodulation approach targeting the TREM-1 pathway to manage excessive inflammation. Its lead product, nangibotide (also known as LR12), is a first-in-class TREM-1 inhibitor designed to address severe conditions such as septic shock and myocardial infarction. Inotrem is also advancing a program aimed at treating chronic inflammatory diseases, leveraging its proprietary technology platform to develop new therapeutic modalities.

Ellisphere is a reference for decision-making information, supporting and securing the decision-making of company executives and decision-makers in France and internationally via the BIGnet network, by providing them with economic and financial information on their trading partners.

AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derived peptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.

99 Advisory is a banking and insurance sectors are facing radical changes in their environments.

Travelsoft SAS, founded in 2016 and based in Paris, France, develops software solutions specifically tailored for the travel industry. The company offers Orchestra, a Software-as-a-Service platform designed to assist professionals in producing, administrating, distributing, and managing leisure services within the travel sector. Through its innovative software offerings, Travelsoft aims to enhance operational efficiency and streamline processes for various stakeholders in the travel market.

SANIFIT is a biotechnology company focused on treatments for calcification disorders. SANIFIT started activities in 2007 and has now operations in Spain and Switzerland.

A company that provides solutions for critical electronic and optronic system testing globally.

HR Path is a global consultancy specializing in human capital management, with a focus on HR Systems Integration, HR Outsourcing, and HR Business Consulting. Founded in 2001 by François Boulet and Cyril Courtin, the company is headquartered in Paris and operates in 13 countries across North America, Europe, and the Middle East, employing over 500 consultants. HR Path offers a range of software solutions, including proprietary tools like BiHRdy for business intelligence, Pandore for HR and payroll management, and Geef for talent management. Additionally, it serves as an authorized reseller for various software solutions in the French market, including those from SAP and Oracle HCM. With a diverse client portfolio that includes large corporations, small and medium-sized enterprises, and public sector organizations, HR Path generates approximately €60 million in annual revenue, supporting clients in their digital transformation and enhancing the efficiency of HR operations through technology.

Tournus Equipement manufactures stainless steel environments for professional kitchens and supermarket fish counters. It offers mobile, modular, and customizable professional kitchens; regeneration ovens, pans and grids, warmers, sterilizing cabinets, gutters and floor drains, trolleys, containers, insect-killers, fish counters, wash-basins, dishwashing equipment, kitchen units, catering units, sinks, units, dustbins, shelving products, temperature reheating products, warming cabinets, coolers, and tables; self-service lines for meal distribution; custom equipment; and bins and tables for loading and unloading dishwashers.

Verbraeken Infra builds and renovates utility infrastructure networks for gas, water, electricity and telecom companies. Vebraeken-Infra generates sales of € 140 million annually, with 1.000 employees across Belgium, France and Germany. Waterland supports Infra Group in its continued expansion in Europe and beyond. This growth strategy resulted in expansion of Verbraeken-Infra’s footprint both organically as well as through acquisitions in France, Germany and the Benelux and has strengthened Verbraeken-Infra’s leading market position in Belgium.

Arvelle Therapeutics GmbH, a biopharmaceutical company, focuses on solutions for patients suffering from CNS disorders. It is involved in the development and commercialization of cenobamate, an investigational antiepileptic drug in the European market. The company was founded in 2019 and is headquartered in Zug, Switzerland.

Grey Wolf Therapeutics, a biotechnology company, develops immunotherapies that illuminate non-responsive tumors for destruction by the immune system. The company was incorporated in 2017 and is based in Oxford, United Kingdom.

HighLife SAS is a medtech company that specializes in developing a novel transcatheter mitral valve replacement system aimed at treating patients with mitral regurgitation. Founded in 2010 and headquartered in Paris, France, with an additional office in Irvine, California, the company focuses on providing a minimally invasive prosthetic mitral valve that can be implanted on a beating heart. This approach preserves the native valve structure and respects the surrounding anatomy, ensuring reduced trauma during surgical procedures. HighLife's technology is designed for ease and safety of use, as well as optimal treatment outcomes, allowing for delivery through a transseptal passage via the femoral vein. The system is currently undergoing clinical evaluation to assess its effectiveness in addressing severe heart conditions.

Atlantic Therapeutics is a medical technology company that develops pelvic floor muscle strengthening and nerve stimulation products. The company's devices focus on the treatment of all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor, enabling bladder patients to treat their conditions associated with pelvic floor weakness. Its products are backed by strong clinical evidence and subjected to controlled trials. It was established in Galway, Galway in 2013.

Lease Protect has specialized in the fight against shrinkage by offering a range of products and services for video surveillance, security gates and customer counting. Under the leadership of its leaders, the offer focused specifically on the small and medium-sized business market thanks to local proximity, responsiveness enabled by the integration of the latest technologies connected to their equipment, and innovative financing solutions. Leasing products and services.

exciva is a Provider of targeted drug rescue program intended to involve pharmaceutical research and development based in Heidelberg, Germany. The company's program has been formulated for developing symptomatic and disease-modifying treatments, therapies, cures, prophylactics, supplements, formulations and methods of making and using such compositions, enabling the healthcare industry to access their program for rescuing and reusing approved drugs for new indications and new uses.

Atlantic Therapeutics is a medical technology company that develops pelvic floor muscle strengthening and nerve stimulation products. The company's devices focus on the treatment of all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor, enabling bladder patients to treat their conditions associated with pelvic floor weakness. Its products are backed by strong clinical evidence and subjected to controlled trials. It was established in Galway, Galway in 2013.

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.

Solware Group operates as a software publisher for actors in the medico-social sector. Solware Group offer innovative, robust and scalable software that responds appropriately to the needs of users and the challenges of their business dailies.

BioClinic operates medical analysis laboratories in the Ile-de-France region. The company was founded in 1995 and is based in Paris, France.

Groupe JORYF is specialist group of housing construction in Ile-de-France.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer treatments that target DNA damage response (DDR) pathways. Founded in 2015, the company aims to create first-in-class therapies that selectively kill cancer cells by exploiting the mechanisms involved in DNA repair. Its product pipeline features several promising candidates, including DNA polymerase theta (Polθ) and an in-licensed program targeting a novel DDR protein. Artios collaborates with Cancer Research Technology and leading researchers in the field to advance its development efforts. The company's leadership comprises experts with extensive experience in DDR drug discovery, and it has garnered investment from notable entities, including SV Life Sciences and AbbVie Ventures.

ReViral is a developer of antiviral drugs designed to help patients and enlarge the antiviral market by developing novel first-in-class compounds. The company's antiviral drugs is a fusion inhibitor of RSV which is a highly potent, novel small molecule and is being developed to treat RSV in patients with severe disease including neonates, enabling patients to be treated who are infected with respiratory syncytial virus (RSV) by developing novel compounds.

Skill and You is the leading provider of vocational e-learning in France with its commitments to innovation and professionalism. Employment is a major issue today, and Skill and You is positioned to deliver to learners real results and qualifications (BAC PRO, BEP, BP, BTS, CAP) via our effective pedagogy and adaptable education technology. Leveraging our group’s experiences and deep knowledge, we’ve built a strong track record of successful schools across sectors, empowering learners to change their lives.

Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.

orbility is a provider of off-street parking applications and programs.The company's parking assistance tools offers complete operational and management control of the car parking system being used. Its client base include airports, shopping centers, airports, municipalities, public and private operators.

TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

ENYO Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, focused on drug discovery and development for acute and chronic viral infections. Founded in 2014 by a group of scientists from the Infectiology Research Center, the company has established a unique platform to identify intracellular therapeutic targets and molecules, particularly for human pathogens. ENYO Pharma is developing treatments for significant viral infections, with ongoing programs targeting chronic hepatitis B and severe influenza. Its lead compound, EYP001, is designed to modulate FXR and reduce viral replication, while EYP002 is currently undergoing preclinical studies. The company aims to advance its pipeline into Phase II clinical trials and collaborates closely with research institutions to leverage innovative therapeutic strategies. ENYO Pharma is committed to addressing unmet medical needs in infectious and metabolic diseases, positioning itself as a leader in antiviral therapies.

Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms. The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments that retain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

Corvidia Therapeutics, Inc. is a biotechnology company based in Waltham, Massachusetts, focused on developing precision therapies for cardiovascular and renal conditions. Established in 2014, the company operates as a subsidiary of Novo Nordisk A/S. Corvidia specializes in researching and commercializing innovative treatments for chronic kidney disease, atherosclerotic cardiovascular disease, inflammation, and high triglyceride-induced acute pancreatitis. By identifying patients with unique sensitivities to specific biological pathways, Corvidia aims to advance the development of transformative therapies that address the complex interplay between cardiovascular and renal health.

MMI S.r.l manufactures and develops micro instruments to support surgical interventions at a dimensional scale. The company develops wristed micro instruments and their fabrication process. The company also develops and offers robotic platform. The company's proprietary robotic platform and wristed micro instruments simplifies reconstruction procedures after traumatic injuries and after tumor removal in breast, head, and bones. The company was founded in 2015 and is headquartered in Calci, Italy.

BIOGROUP-LCD, a major French player in local medical biology, supports more than 20,000 patients every day and offers more than 2000 routine and specialized daily examinations, based on performance and technological innovation. Partner at every moment between the patient and the medical profession, your laboratory participates in the screening, diagnosis, monitoring and prognosis of the most common pathologies to the most demanding, throughout your course of care. BIOGROUP-LCD develops for this purpose all its human and technological resources. The team of qualified, qualified medical biologists follows continuous and regular training.

The WALOR Group (12 production sites in 5 countries, 1600 employees) is the European leader in the mechanical parts market, specializing in the design and production of forgings and machined parts (engines, gearbox, steering ...) and counts among its customers the largest manufacturers, system operators and automotive suppliers.

ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.

GLOBE Groupe sa provides advertising services. The company offers strategic planning and communication strategy services. It also provides advertising, non-media planning, talent castings, recruitment, training, and payroll services. The company also offers storage, kitting, dispatch, cold-chain logistics, stand installation, after-sales checks, parking reservations, and permits. It caters to consumer goods, media, retailers, media, and recruitment industries. GLOBE Groupe sa is based in Paris, France.

Created in 2016, TimeOne is a marketing services group formed from two online marketing specialists, Public-Idées and Place des Leads. The group’s core offering is to provide content and data solutions. With a well-established reputation in prescriptive marketing and a common technological base (DMP), TimeOne is founded on innovation and realized through research and development. TimeOne offers a comprehensive range of online marketing solutions: Programmatic, Native, Performance, digital Marketplace, Publishing and Mobile. The company has a presence in France, in the United-Kingdom, in Spain, Italy, South Africa, Asia and South America.

SA La Vie Saine engages in the retail of organic products. Its products include dairy products, food supplements, fruits and vegetables, grocery, bakery, hygiene products, meat, and wine. The company was founded in 1952 and is headquartered in Dijon, France.

Groupe conseil en marketing client et communication, nativement inspiré par la data et les nouvelles technologies.

Allodiagnostic SAS offers real estate diagnoses, such as termites, electrical, and energy performance on behalf of private individuals during the rental or sale of a property. The company was incorporated in 2001 and is based in Paris, France. As of July 21, 2017, Allodiagnostic SAS operates as a subsidiary of Edmond de Rothschild (France).

IN’TECH MEDICAL is an industry leader in the development and manufacturing of surgical instruments for the Orthopaedic industry. IN’TECH delivers expertise in all aspects of surgical instrument including development and manufacturing. Their services encompass contract manufacturing and contract designing. IN’TECH have a strong track record of turning original ideas into new solutions for their customers.

Complexa, Inc. is a biopharmaceutical company based in Berwyn, Pennsylvania, focused on developing therapies for severe and life-threatening diseases associated with fibrosis and inflammation. Founded in 2008, the company is advancing its lead compound, CXA-10, an oral nitrated fatty acid, for the treatment of conditions such as focal segmental glomerulosclerosis and pulmonary arterial hypertension. Complexa utilizes proprietary technology to synthesize endogenous nitro-fatty acids and related mediators, which are designed to address a range of inflammatory, fibrotic, and central nervous system diseases. These nitro-fatty acids function as cell-signaling agents that regulate key inflammatory pathways, thereby enhancing the body's natural mechanisms for resolving tissue injury and promoting repair.

Sarawak Group is a company specialized in setting up Sales-, Merchandising- and Brand Activation services. We seek to accelerate the performance and results of sales of products and services of our customers.

STUDIA S.A.S. offers consultancy services specializing in enterprise content management (ECM) and document engineering. The company offers services like advice for implementation, strategic consulting, advice for digital data processing, support services, industrial engineering services, risk control, and documentary engineering. Additionally, it also offers digital transition and business support services. It serves customers in sectors, including energy, industry, tertiary/public, and defense. STUDIA S.A.S. was founded in 2009 and is based in Meyreuil, France.

Founded in 2001, the Groupe 3S , thanks to the synergy of the expertise of its subsidiaries and its financial soundness is now one of the world leaders in services. Several of his companies are focused on assistance to airline ground handling and other services from the airport managers.

LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases, including: hemophilia, HIV/AIDS and methylmalonic acidemia (MMA). Our proprietary technology based on the non-pathogenic Adeno-Associated Viral (AAV) vector offers superior efficiency and safety compared to all competitors on the market, and is uniquely suited for the treatment of children as well as adults.

Klaxcar France S.A., founded in 1993 and headquartered in Dourdan, France, specializes in manufacturing automotive spare parts. The company focuses on the aftermarket sector, offering products that meet Original Part quality standards while maintaining competitive pricing. Klaxcar aims to provide reliable solutions for automotive needs, catering to a diverse range of customers in the automotive industry.

Minafin is a global fine chemicals developer and manufacturer. Minafin develops and manufactures active ingredients, organic intermediates, and specialty fine chemicals for the life science industries and technical applications.

Genoa Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of idiopathic pulmonary fibrosis (IPF). It develops GP-101, an aerosol pirfenidone formulation for direct inhalation delivery to the lungs for the treatment of IPF. The company was founded in 2011 and is based in San Diego, California.

Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.

Bacacier is a manufacture steel and the associated CO2 emissions have been halved.

Medlumics S.L. designs and manufactures catheter based systems for the treatment of supra ventricular tachycardias. The company develops integrated photonic devices using optical coherence tomography technology, a light based diagnostic technique to provide sectional information about tissue. Medlumics S.L. was founded in 2009 and is based in Tres Cantos, Spain.

Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other severe respiratory diseases. Its therapies rapidly advance AP01 for the treatment of IPF, provides additional pipeline candidates for IPF, improve the care and outcomes of severe respiratory diseases, and develop novel inhaled therapeutics. Avalyn Pharma was established in 2011 and is headquartered in Seattle, Washington.

Groupe NetCo specializes in the design, manufacture, assembly, maintenance, and installation of conveyor systems, including both belt and roller types. The company offers a diverse range of conveyor belts made from rubber and various polymers, along with specialized accessories such as wipers, rollers, and drive pulleys. NetCo also provides services like on-site installation, training for conveyor belt operation, and custom transformations of conveyor belts. Serving a wide array of industries, including waste management, logistics, agrifood, pharmaceuticals, and energy sectors, the company has established itself as a leader in the domestic market within a decade of operation. Founded in 1902 and based in Bordeaux, France, Groupe NetCo was previously known as PERRIEZ and rebranded in 1999.

Specialist manufacturer and private labeller of chemicals and solvents. Retail / Wholesale packaging and distribution services.

The Reefer Group SL through its subsidiaries designs and manufactures refrigerated semi trailers. manufactures refrigerated vehicles for temperature controlled transportation applications in France and internationally. It offers new and used semi-trailers and trucks; other products, such as tractor-trailers, removable bodies, and utility vehicles; and used vehicles for road haulage of meat, dairy products, fruits and vegetables, flowers, and pharmaceutical products. The company also offers spare parts, servicing and repairs, and rebuilding services; and services, such as liveries, rentals, after-sales training, vehicle upgrades and special equipment, and sells second-hand vehicles. It offers products through its sales network. The company was incorporated in 2015 and is based in Alzira, Spain.

MS Vacances SAS offers boarding, hospitality and lodging services. The company was incorporated in 1992 and is based in Nantes, France.

Mondial Pet Distribution S.p.A. distributes hygiene and personal products for animals, under the Fortesan brand. The company is based in Fossano, Italy. As of April 24, 2018, Mondial Pet Distribution S.p.A. operates as a subsidiary of Agrifarma S.p.A.

Fortesan cares about your animals and takes care of them.

Orchestra is an online platform dedicated to the travel industry. It enables professionals to produce, administrate, distribute, and manage leisure offers on many distribution channels. Orchestra is based in Lopera, Spain.

Founded in 2006, Foncière Atland is a real estate investment trust (REIT), active in Ile-de-France and other regions. The firm invests, asset manages and executes turnkey developments and also manages collective real estate funds through its subsidiary, Voisin. The company's shareholders include Crédit Foncier and Tikéhau Capital, as well as Edmond de Rothschild Investment Partners at Groupe Atland.

The IPSIDE firm assists and advises clients in the process of obtaining, operation and defense of their patents of invention, both in France and abroad. Other ways to protect technical inventions are also included to allow the implementation of the overall strategy of the most appropriate Intellectual Property for the company. We also assist our clients in the development of their technical and legal strategies for operation of their inventions.

Verona Pharma is a clinical-stage biotechnology company based in London, dedicated to the discovery and development of therapies for chronic respiratory diseases. The company focuses on addressing unmet medical needs related to conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Its lead product candidate, ensifentrine, is an inhaled dual inhibitor of phosphodiesterase enzymes that functions as both a bronchodilator and an anti-inflammatory agent. Currently, ensifentrine is undergoing clinical development, with formulations such as nebulized and dry powder inhalers being tested for the maintenance treatment of COPD. Verona Pharma aims to enhance the health and quality of life for individuals affected by these respiratory conditions. Founded in 2005, the company continues to advance its innovative therapeutic solutions.

Allecra Therapeutics GmbH develops pharmaceuticals to treat gram-negative multi drug-resistant bacterial infections. The company was founded in 2013 and is based in Weil am Rhein, Germany.

MedDay is an innovative biopharmaceutical company specializing in the development of therapies for neurodegenerative diseases by targeting key neurometabolic pathways. Established in 2016, the company aims to create disease-modifying treatments that provide solutions for patients, caregivers, and the healthcare community, addressing significant unmet medical needs. MedDay's focus is on investigating brain metabolism to develop neuroprotective and neurorepair therapies, with promising clinical trial outcomes guiding their research efforts. By exploring disrupted metabolic pathways in the central nervous system, MedDay seeks to enhance future treatment options for individuals suffering from nervous system disorders.

La Toulousaine is a French company based in Escalquens, established in 1975, that specializes in the design and manufacture of various building materials. The company produces an extensive range of products, including gates, fences, garage doors, sectional doors, shutters, and security railings. Additionally, La Toulousaine offers metal curtains and mechanical shutters tailored for commercial establishments. Its product line also includes automatic systems and accessories to enhance functionality and security. With a focus on both residential and industrial applications, La Toulousaine serves a diverse clientele in the building materials sector.

Sogetrel is a major player in the telecoms market. Integrator of networks and communication systems for digital irrigation of territories, the Group has established itself as the preferred partner of major operators, public and private contractors, and local authorities, particularly in the deployment of Very High Speed ​​networks.

Fondée en 1999, SFAM est une société de courtage en assurances, filiale de SFK Group. Dotée d’un capital de 2 000 000 d’euros, SFAM crée, commercialise et gère des solutions et des services d'assurance affinitaires. A ses débuts, SFAM se spécialise dans la conception de produits d'assurance destinés exclusivement aux domaines du multimédia et de la téléphonie. Puis elle élargit petit à petit son offre au domaine de l'optique, de l'électroménager, de l'e-commerce, de la protection conducteur et plus récemment à l’ensemble des produits connectés du foyer. Toujours attentive à l'évolution des besoins de ses clients et du marché, la société intègre au fil des années de nouveaux domaines d'activité et accroît par la même occasion sa notoriété. Soucieuse d'innover et de développer les services attendus par ses clients, SFAM propose dès 2009, dans le cadre de ses solutions d'assurances mobile et multimédia, la prise en compte de la perte de l’appareil assuré et de la négligence dans la réalisation des sinistres. En 2013, elle innove de nouveau en intégrant aux contrats d’assurance la reprise des anciens téléphones portables. La flexibilité des garanties et l'éventail des formules proposées par SFAM sont très certainement au cœur de sa réussite. En recherche constante d’équilibre entre ses offres commerciales, leur rapport qualité-prix et la qualité des garanties proposées, SFAM se positionne rapidement comme un acteur majeur de son secteur d'activité. Elle compte actuellement plus de 500 000 clients et de 1500 partenaires installés sur l’ensemble du territoire. Dans sa relation avec ses partenaires commerciaux, SFAM met un point d’honneur à leur délivrer la meilleure formation et à les accompagner dans l’amélioration de leur service clientèle. Elle met ainsi ses 110 collaborateurs à leur disposition afin de leur offrir leur expertise et leur savoir-faire dans les différents domaines d'activité. Egalement très proche de ses adhérents, la société SFAM accorde également une place essentielle à son service clientèle. Elle met en effet à leur disposition un système de traitement des demandes et de gestion des réponses permettant de satisfaire aux mieux ses clients. Par le biais d'un service client multicanal, la SFAM offre une écoute et une disponibilité très large à l'ensemble de ses interlocuteurs. SFAM ne cesse de poursuivre son ascension dans le monde des assurances ; le secret de son succès étant sans nul doute la combinaison de son esprit novateur et de sa proximité avec ses clients.

Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.

GamaMabs Pharma SA engages in the development of a new therapeutic antibody for the treatment of ovarian cancer. The company was founded in 2013 and is based in Toulouse, France.

REALEASE Capital offers leasing and financing solutions to the manufacturers of material of videoconference. The company was formerly known as Comiris Capital. The company was founded in 1986 and is based in Puteaux, France.